Skip to content
Delayed ~15 min

MPLT MAPLIGHT THERAPEUTICS

Health Care · Russell 2000

Next earnings: Thu 12 Nov 2026 · estimated

What 18 analyst firms say about MAPLIGHT THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works

6.93 USD+0.71 (+11.41%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+314.3%to the avg target 28.71 USD+21.78 USD
Buy 12 · Hold 4 · Sell 0

16 rated views · 19 analyst/firm records · 18 firms

Latest report31 Aug 2026avg report date 16 Jul
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8068
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8046

Recent analyst activity · last 90 days

Our tracked history has 7 reports on MPLT from 6 analyst firms in the last 90 days (18 firms in the past year).

Comparing each firm's latest target with its previous one: 1 raised its price target and 3 lowered it.

Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.

Latest observed target change: Needham raised its target from $42.00 (set 22 Jun 2026) to $43.00 on 31 Aug 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BenchmarkUnnamed analystBuy22 Jun 2026—
BMO Capital MarketsEvan SeigermanBuy20 Jul 202620.00 USD
BMO Capital MarketsMalcolm HoffmanBuy20 Jul 202646.00 USD
Canaccord GenuitySumant Kulkarni—14 Aug 202621.00 USD
Craig-HallumAdam VogelBuy28 Jul 202625.00 USD
GuggenheimMaddalena D CaiatiHold6 Oct 2026—
H.C. WainwrightRaghuram SelvarajuBuy28 Jul 202626.00 USD
JefferiesAndrew TsaiBuy15 May 202625.00 USD
Leerink PartnersMarc GoodmanBuy21 Jul 202620.00 USD
Lifesci CapitalFrancois BriseboisBuy14 May 202645.00 USD
Morgan StanleySean LaamanHold28 Jul 202621.00 USD
NeedhamAmi FadiaBuy31 Aug 202643.00 USD
Raymond JamesTiago Fauth—14 Aug 202631.00 USD
StifelPaul MatteisBuy1 Jun 202636.00 USD
TD CowenJoseph ThomeBuy8 Apr 2026—
UBSAshwani VermaHold10 Aug 202613.00 USD
Weiss RatingsUnnamed analyst—23 Oct 2026—
Wolfe ResearchRudy LiBuy10 Jul 202630.00 USD
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 08:12 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.